We determined the serum levels and tumor tissue expression of MMP-2 and TIMP-2 in 72 CRC patients in relation to clinicopathological features of cancer as well as the prognostic significance of all variables tested for CRC patients’ survival. The gene discussed is TIMP2; the disease is cancer.